SlideShare a Scribd company logo
POLYMERS FOR COATING
OVERVIEW Process of coating Types of coating Mechanism of coating Factors affecting the process USP standards & specifications Principle of Plasticization Plasticizers Role of polymer Polymers used for conventional coating Polymers used for Enteric coating Commercially available coating systems Case study Future prospective
Process of Coating Application of thin polymeric film over the core surface( tablet, pellets, granules & dosage units ) to form a smooth surface with uniform distribution optimizing the quality of product with both -Visual -Functional point of views.
Advantages of Coating Improves aesthetic qualities of product Masking of unpleasant taste & odor Improving patient compliance Facilitating handling Increased product stability Modifying drug release behavior ??????
Types of Coating
Mechanism of coating
Events During Film formation Initial rapid evaporation of solvent from the atomized droplets of coating liquid causing: a) increase in polymer concentration (viscosity) b)reduction in volume of droplets Further loss of solvent from the film at a slower rate (diffusion controlled)  Immobilization of polymer molecules at solidification point (tablet surface) Further gradual loss of solvent at a much reduced rate
Factors affecting the process Factors has influence on (parameter) Tablet  Ingredients Porosity Surface roughness Wetting of coating liquid Dry film adhesion Spreading of coating solution Coating liquid Solids content Viscosity  of solution Surface tension Coating liquid viscosity Spreading and coalescence Wetting, spreading & coalescence 3. Process of drying Drying rate Heat applied Viscosity of coating liquid &Structure of dried coating Development of internal stress & Mechanical properties
USP Standards & Specifications Enteric coated tablets must tolerate agitation in simulated gastric fluid test solution at 37± 2 ◦ c (no discs).  After 1 hour of exposure in simulated gastric fluid, tablets must present no evidence of disintegration, cracking or softening.  Then a disc is added to each tube, and the test is continued using simulated intestinal fluid maintained at the same temperature as mentioned above. The test is conducted for 2 hours to the time specified in the individual monograph.  The batch passes the test if all tablets disintegrate. If 1 or 2 tablets fail to disintegrate completely, the test is repeated on 12 additional tablets. At the end at least 16 out of 18 tablets should disintegrate within the specified time in order to pass the test.
Plasticization Polymers used for pharmaceutical dosage forms for coating are generally amorphous in nature.  Unfortunately Glass transition temperature of most of the polymers are in excess of conditions exposed for the pharmaceutical manufacturing.  Thus one needs to incorporate plasticizer basically for two main reasons:- Modification of polymer properties so as to impart flexibility which reduces the T g  of amorphous polymer. To facilitate the processing of dosage form at substantial temperature conditions to protect the integrity of active ingredient.
Plasticizers  Class Examples  Polyhydric alcohols  Propylene glycol Glycerol Polyethylene glycol Acetate esters Glyceryl triacetate Triethyl citrate Acetyl triethyl citrate Phthalate esters Diethyl phthalate  Glycerides Acetylated monoglycerides Oils Castor and mineral oil.
Polymers
Polymers for conventional coating Class Examples Cellulosics HPMC HPC HEC MC (Methocel) Na-CMC EC (Ethocel) Vinyls PVP Glycols PEG Acrylics Co-polymers such as methyl methacrylate, ethyl methacrylate
Hydroxy propyl methyl cellulose (HPMC) Material  of choice for air suspension and pan spray coating. Reasons   High moisture stability, photo-stability and thermal stability Flexibility, tasteless and odorless. Compatible with additives with additives and colorants. Solubility characteristic of the polymer in GIT.
Ethyl cellulose (EC) Various viscosity grades are available. degree of Ethoxy substitution. Completely insoluble in water and G.I. fluids. Soluble in wide variety of organic solvents Non-toxic odorless and tasteless. Requires plasticizers. Pseudo latex systems using aqueous polymeric dispersions can be formed using ethyl cellulose having low viscosity and high solid content
Sodium Carboxy Methyl Cellulose (Na-CMC) Available in low, medium, high and extra high viscosity grades. Easily dispersed in water to form colloidal dispersions. Not a material of choice for coating based on organic solvents as it is insoluble in most organic solvents. Preferably used for aqueous film coating solutions with high coating efficiency equipment.
Polyethylene Glycol (PEG) PEG is available in grade ranging from 200-8000 PEG has low contact angle –penetration into powder bed and make contact with substrate surface. Desirable melting range Molecular weight. Waxy and hygroscopic, soften readily at moderately elevated temperatures.  Low molecular weight PEG’s are used as plasticizers in coating solutions rather than as polymers.
Acrylate polymers Acrylate polymers are generally marketed as Eudragits.  Eudragit RL and RS are copolymers synthesized from methacrylic acid esters with low content of quaternary ammonium groups.
Polymers used for enteric coating.
Enteric Coating Polymers Polymer Characteristics Cellulose Acetate Phthalate Susceptible  to Hydrolysis Cellulose Acetate Trimellitate Susceptible  to Hydrolysis Polyvinyl Acetate Phthalate Susceptible  to Hydrolysis HPMC-Phthalate Susceptible  to Hydrolysis HPMC-Acetate Succinate Susceptible  to Hydrolysis Poly (MA -EA) 1 : 1 ------ Poly (MA -MMA) 1 : 1 High Dissolution pH Poly (MA -MMA) 1 : 2 High Dissolution pH
Cellulose Acetate Phthalate (CAP) Relatively hygroscopic and permeable to gastric fluids and moisture. Films formed from CAP are brittle. Usually formulated with hydrophobic excipients to achieve a better enteric film.  Colloidal dispersion of latex particles comprising of polymeric spheres of CAP (aquateric) have been developed and commercially utilized. Dissolves only above pH 6 and delays the absorption of drugs
HPMC-phthalate Dissolves at a relatively lower pH (5-5.5) than CAP or acrylic copolymers. This Solubility characteristic may result in higher bioavailability of certain drugs. Different grades are available HPMCP-50,HPMCP-55 and HPMCP-55S. Stability is higher compared to CAP Absence of labile acetyl groups
Commercially available enteric coating systems Product Polymer Form Characteristic Eudragit L30D Poly (MA-EA) 1:1 Latex Dispersion Essentially contains only polymer Eudragit L 10055 Poly (MA-EA) 1:1 Spray Dried latex Dispersed in water + allkali Coateric  PVAP Dry powder Dispersed in water + ammonia Aquateric CAP Spray dried pseudo latex Dispersed in water  CAP CAP Dry powder Dissolved in water + alkali CAT CAT Dry powder Dissolved in water + alkali HPMC-P HPMC Dry powder Dispersed in water
Eudragits
Eudragits  Eudragits Availability applications Dissolution properties Eudragit L 100-55 Powder Drug delivery in duodenum > 5.5 Eudragit D 100-55 Aqueous dispersion 30% Drug delivery duodenum >5.5 Eudragit L 100 Powder Drug delivery in jejunum >6.0 Eudragit S 100 Powder Drug delivery in ileum >7.0 Eudragit FS 30 D Aqueous Dispersion 30% drug delivery in colons. >7.0
Cont’d The EUDRAGIT   grades for enteric coatings are based on anionic polymers of methacrylic acid and methacrylates. They contain –COOH as a functional group. They dissolve at ranges from pH 5.5 to pH 7. Application benefits of enteric EUDRAGIT   coatings: PH-dependent drug release Protection of actives sensitive to gastric fluid Protection of gastric mucosa from aggressive actives Increase in drug effectiveness Good storage stability GI and colon targeting
Use of Hot melt extrusion in Enteric coating of tablets “ The manufacture and characterization of hot-melt extruded enteric tablets” Eudragit L100-55, an enteric polymer, was pre-plasticized with triethyl citrate (TEC) and citric acid and subsequently dry-mixed with 5-aminosalicylic acid, a model active pharmaceutical ingredient (API). Powder blends were hot-melt extruded as cylinders, cut into tablets.  The authors concluded that Increasing the concentration of TEC significantly lowered the glass transition temperature ( T g ) of Eudragit L100-55 and reduced temperatures necessary for extrusion as well as the die pressure.
Release profile Influence of method of manufacture on the release of 5-ASA from Eudragit L100-55 tablets in 0.1 N HCl dissolution media (pH 1.2). () HME tablet; (■) compressed tablet with hardness value of 62 ± 2 N; (○) compressed tablet with hardness value of 230 N ± 12 N.
Cont’d.. This leads to suggest that hot melt extrusion, a versatile process can be utilized to decrease the compression pressure in order to optimize formulation parameters affecting compressional behavior of materials such as MCC that in conventional enteric coating techniques employ high compressional pressures.
Case study 2 Controlled release of dual drug-loaded hydroxypropyl methylcellulose matrix tablet using drug-containing polymeric coatings. By Beom-Jin Lee ,  , Seung-Goo Ryu and Jing-Hao Cui. Dual drug loaded HPMC matrix tablet that conatins drug in inner tablet core and outer coated layers. Aqueous based Eudragit RS 30 D dispersionis used.
Cont’d.. The dual drug-loaded HPMC matrix tablet gave a biphasic linear release, showing a zero-order for 4 h (first) followed by another zero-order release. The current dual drug-loaded HPMC matrix tablet, showing biphasic release profiles may provide an alternative to deliver drugs with circadian rhythmic behaviors in the body. The dual drug-loaded coating method is also interesting for the modified release of poorly water-soluble drugs because solubilizers and other additives can be added in drug-containing polymeric coating dispersions.
Future prospects Coating can be dated as back as in ancient times when an experienced individual would dip a bitter tablet into sugar syrup. Since then the process of coating has been constantly an area of interest for oral dosage forms. With the emergence of newer polymers that are pH dependent, acid resistant and many other properties.
Cont’d… Utilization of dual coating in case of polymers such as HPMC may result into development of newer techniques in case of coating. Thus it can be concluded that coating has been, is and shall continue to be one of the most promising area in formulation of oral dosage forms for improved health care.
Thank us “If we knew what we were doing, it would not be called research”

More Related Content

DOCX
Enteric coating of pharmaceutical products
PPTX
Enteric coating
PPTX
Tablet coating by ankita yagnik
PPTX
Tablet types and Excipients
PPTX
Ch 4 tablet coating industrial pharmacy
PPT
Microencapsulation power point
PPTX
Co processed excipient
PPTX
EUDRAGITS
Enteric coating of pharmaceutical products
Enteric coating
Tablet coating by ankita yagnik
Tablet types and Excipients
Ch 4 tablet coating industrial pharmacy
Microencapsulation power point
Co processed excipient
EUDRAGITS

What's hot (20)

PPT
co-processed excipients ppt
PPTX
Presentation for Tablet Coating
PDF
Pharmaceutical excipients
PPTX
All about Tablets (Pharma)
PPT
Challenges in development of orally disintegrating and dispersible
PPTX
Coating Process of Tablets
PPTX
Liquid orals for pharm.D
PPTX
Excipients
PPTX
Tablets
PDF
Coating 3
PPTX
Pharmaceutical Additives
PDF
encapsulation in the food industry
PPTX
Coating technology
PPTX
DILUENTS AND DISINTEGRANTS
PPTX
Recent innovation in liquid dosage form 1by sachin
PPTX
Tablet coating2
PPTX
Emulsion and suspensions
PPTX
Added substances for parenterals
PPTX
Microencapsulation
co-processed excipients ppt
Presentation for Tablet Coating
Pharmaceutical excipients
All about Tablets (Pharma)
Challenges in development of orally disintegrating and dispersible
Coating Process of Tablets
Liquid orals for pharm.D
Excipients
Tablets
Coating 3
Pharmaceutical Additives
encapsulation in the food industry
Coating technology
DILUENTS AND DISINTEGRANTS
Recent innovation in liquid dosage form 1by sachin
Tablet coating2
Emulsion and suspensions
Added substances for parenterals
Microencapsulation
Ad

Similar to Paavan Polymers (20)

PPTX
Tablet coating3
PPTX
Anju coatg
PPTX
Coating technology
PPTX
TABLET COATING
PDF
Film Coated Tablet and Film Coating raw materials.pdf
PPTX
8.1.Thickener.pptx for textile students.
PPTX
8.1.Thickener.pptx for textile students.
PPT
Plasticizer Presentation Final
PPTX
Self emulsifying drug delivery system
PPT
Tablet coating process
PPTX
PMT seminar 11.pptx
PPTX
Pharmaceutical excipents -advanced study
PPTX
PHARMACEUTICAL TABLETS.pptx
PPTX
Coating of Pharmaceutical Tablet
PPTX
Types of tablet coating
PPT
Chapter on Microencapsulation and mdds
PDF
IOSR Journal of Pharmacy (IOSRPHR)
PDF
Wurster Fluidised Bed Coating of Microparticles: Towards Scalable Production ...
PPTX
Tablet coating - industrial pharmacy
Tablet coating3
Anju coatg
Coating technology
TABLET COATING
Film Coated Tablet and Film Coating raw materials.pdf
8.1.Thickener.pptx for textile students.
8.1.Thickener.pptx for textile students.
Plasticizer Presentation Final
Self emulsifying drug delivery system
Tablet coating process
PMT seminar 11.pptx
Pharmaceutical excipents -advanced study
PHARMACEUTICAL TABLETS.pptx
Coating of Pharmaceutical Tablet
Types of tablet coating
Chapter on Microencapsulation and mdds
IOSR Journal of Pharmacy (IOSRPHR)
Wurster Fluidised Bed Coating of Microparticles: Towards Scalable Production ...
Tablet coating - industrial pharmacy
Ad

Recently uploaded (20)

PDF
WOOl fibre morphology and structure.pdf for textiles
PDF
1 - Historical Antecedents, Social Consideration.pdf
PDF
Hindi spoken digit analysis for native and non-native speakers
PPTX
Chapter 5: Probability Theory and Statistics
PDF
7 ChatGPT Prompts to Help You Define Your Ideal Customer Profile.pdf
PPTX
Programs and apps: productivity, graphics, security and other tools
PDF
Accuracy of neural networks in brain wave diagnosis of schizophrenia
PDF
NewMind AI Weekly Chronicles - August'25-Week II
PPTX
Digital-Transformation-Roadmap-for-Companies.pptx
PDF
Unlocking AI with Model Context Protocol (MCP)
PDF
Building Integrated photovoltaic BIPV_UPV.pdf
PDF
Getting Started with Data Integration: FME Form 101
PPTX
Group 1 Presentation -Planning and Decision Making .pptx
PDF
Video forgery: An extensive analysis of inter-and intra-frame manipulation al...
PDF
A novel scalable deep ensemble learning framework for big data classification...
PDF
Encapsulation_ Review paper, used for researhc scholars
PPTX
KOM of Painting work and Equipment Insulation REV00 update 25-dec.pptx
PDF
project resource management chapter-09.pdf
PDF
From MVP to Full-Scale Product A Startup’s Software Journey.pdf
PDF
Web App vs Mobile App What Should You Build First.pdf
WOOl fibre morphology and structure.pdf for textiles
1 - Historical Antecedents, Social Consideration.pdf
Hindi spoken digit analysis for native and non-native speakers
Chapter 5: Probability Theory and Statistics
7 ChatGPT Prompts to Help You Define Your Ideal Customer Profile.pdf
Programs and apps: productivity, graphics, security and other tools
Accuracy of neural networks in brain wave diagnosis of schizophrenia
NewMind AI Weekly Chronicles - August'25-Week II
Digital-Transformation-Roadmap-for-Companies.pptx
Unlocking AI with Model Context Protocol (MCP)
Building Integrated photovoltaic BIPV_UPV.pdf
Getting Started with Data Integration: FME Form 101
Group 1 Presentation -Planning and Decision Making .pptx
Video forgery: An extensive analysis of inter-and intra-frame manipulation al...
A novel scalable deep ensemble learning framework for big data classification...
Encapsulation_ Review paper, used for researhc scholars
KOM of Painting work and Equipment Insulation REV00 update 25-dec.pptx
project resource management chapter-09.pdf
From MVP to Full-Scale Product A Startup’s Software Journey.pdf
Web App vs Mobile App What Should You Build First.pdf

Paavan Polymers

  • 2. OVERVIEW Process of coating Types of coating Mechanism of coating Factors affecting the process USP standards & specifications Principle of Plasticization Plasticizers Role of polymer Polymers used for conventional coating Polymers used for Enteric coating Commercially available coating systems Case study Future prospective
  • 3. Process of Coating Application of thin polymeric film over the core surface( tablet, pellets, granules & dosage units ) to form a smooth surface with uniform distribution optimizing the quality of product with both -Visual -Functional point of views.
  • 4. Advantages of Coating Improves aesthetic qualities of product Masking of unpleasant taste & odor Improving patient compliance Facilitating handling Increased product stability Modifying drug release behavior ??????
  • 7. Events During Film formation Initial rapid evaporation of solvent from the atomized droplets of coating liquid causing: a) increase in polymer concentration (viscosity) b)reduction in volume of droplets Further loss of solvent from the film at a slower rate (diffusion controlled) Immobilization of polymer molecules at solidification point (tablet surface) Further gradual loss of solvent at a much reduced rate
  • 8. Factors affecting the process Factors has influence on (parameter) Tablet Ingredients Porosity Surface roughness Wetting of coating liquid Dry film adhesion Spreading of coating solution Coating liquid Solids content Viscosity of solution Surface tension Coating liquid viscosity Spreading and coalescence Wetting, spreading & coalescence 3. Process of drying Drying rate Heat applied Viscosity of coating liquid &Structure of dried coating Development of internal stress & Mechanical properties
  • 9. USP Standards & Specifications Enteric coated tablets must tolerate agitation in simulated gastric fluid test solution at 37± 2 ◦ c (no discs). After 1 hour of exposure in simulated gastric fluid, tablets must present no evidence of disintegration, cracking or softening. Then a disc is added to each tube, and the test is continued using simulated intestinal fluid maintained at the same temperature as mentioned above. The test is conducted for 2 hours to the time specified in the individual monograph. The batch passes the test if all tablets disintegrate. If 1 or 2 tablets fail to disintegrate completely, the test is repeated on 12 additional tablets. At the end at least 16 out of 18 tablets should disintegrate within the specified time in order to pass the test.
  • 10. Plasticization Polymers used for pharmaceutical dosage forms for coating are generally amorphous in nature. Unfortunately Glass transition temperature of most of the polymers are in excess of conditions exposed for the pharmaceutical manufacturing. Thus one needs to incorporate plasticizer basically for two main reasons:- Modification of polymer properties so as to impart flexibility which reduces the T g of amorphous polymer. To facilitate the processing of dosage form at substantial temperature conditions to protect the integrity of active ingredient.
  • 11. Plasticizers Class Examples Polyhydric alcohols Propylene glycol Glycerol Polyethylene glycol Acetate esters Glyceryl triacetate Triethyl citrate Acetyl triethyl citrate Phthalate esters Diethyl phthalate Glycerides Acetylated monoglycerides Oils Castor and mineral oil.
  • 13. Polymers for conventional coating Class Examples Cellulosics HPMC HPC HEC MC (Methocel) Na-CMC EC (Ethocel) Vinyls PVP Glycols PEG Acrylics Co-polymers such as methyl methacrylate, ethyl methacrylate
  • 14. Hydroxy propyl methyl cellulose (HPMC) Material of choice for air suspension and pan spray coating. Reasons High moisture stability, photo-stability and thermal stability Flexibility, tasteless and odorless. Compatible with additives with additives and colorants. Solubility characteristic of the polymer in GIT.
  • 15. Ethyl cellulose (EC) Various viscosity grades are available. degree of Ethoxy substitution. Completely insoluble in water and G.I. fluids. Soluble in wide variety of organic solvents Non-toxic odorless and tasteless. Requires plasticizers. Pseudo latex systems using aqueous polymeric dispersions can be formed using ethyl cellulose having low viscosity and high solid content
  • 16. Sodium Carboxy Methyl Cellulose (Na-CMC) Available in low, medium, high and extra high viscosity grades. Easily dispersed in water to form colloidal dispersions. Not a material of choice for coating based on organic solvents as it is insoluble in most organic solvents. Preferably used for aqueous film coating solutions with high coating efficiency equipment.
  • 17. Polyethylene Glycol (PEG) PEG is available in grade ranging from 200-8000 PEG has low contact angle –penetration into powder bed and make contact with substrate surface. Desirable melting range Molecular weight. Waxy and hygroscopic, soften readily at moderately elevated temperatures. Low molecular weight PEG’s are used as plasticizers in coating solutions rather than as polymers.
  • 18. Acrylate polymers Acrylate polymers are generally marketed as Eudragits. Eudragit RL and RS are copolymers synthesized from methacrylic acid esters with low content of quaternary ammonium groups.
  • 19. Polymers used for enteric coating.
  • 20. Enteric Coating Polymers Polymer Characteristics Cellulose Acetate Phthalate Susceptible to Hydrolysis Cellulose Acetate Trimellitate Susceptible to Hydrolysis Polyvinyl Acetate Phthalate Susceptible to Hydrolysis HPMC-Phthalate Susceptible to Hydrolysis HPMC-Acetate Succinate Susceptible to Hydrolysis Poly (MA -EA) 1 : 1 ------ Poly (MA -MMA) 1 : 1 High Dissolution pH Poly (MA -MMA) 1 : 2 High Dissolution pH
  • 21. Cellulose Acetate Phthalate (CAP) Relatively hygroscopic and permeable to gastric fluids and moisture. Films formed from CAP are brittle. Usually formulated with hydrophobic excipients to achieve a better enteric film. Colloidal dispersion of latex particles comprising of polymeric spheres of CAP (aquateric) have been developed and commercially utilized. Dissolves only above pH 6 and delays the absorption of drugs
  • 22. HPMC-phthalate Dissolves at a relatively lower pH (5-5.5) than CAP or acrylic copolymers. This Solubility characteristic may result in higher bioavailability of certain drugs. Different grades are available HPMCP-50,HPMCP-55 and HPMCP-55S. Stability is higher compared to CAP Absence of labile acetyl groups
  • 23. Commercially available enteric coating systems Product Polymer Form Characteristic Eudragit L30D Poly (MA-EA) 1:1 Latex Dispersion Essentially contains only polymer Eudragit L 10055 Poly (MA-EA) 1:1 Spray Dried latex Dispersed in water + allkali Coateric PVAP Dry powder Dispersed in water + ammonia Aquateric CAP Spray dried pseudo latex Dispersed in water CAP CAP Dry powder Dissolved in water + alkali CAT CAT Dry powder Dissolved in water + alkali HPMC-P HPMC Dry powder Dispersed in water
  • 25. Eudragits Eudragits Availability applications Dissolution properties Eudragit L 100-55 Powder Drug delivery in duodenum > 5.5 Eudragit D 100-55 Aqueous dispersion 30% Drug delivery duodenum >5.5 Eudragit L 100 Powder Drug delivery in jejunum >6.0 Eudragit S 100 Powder Drug delivery in ileum >7.0 Eudragit FS 30 D Aqueous Dispersion 30% drug delivery in colons. >7.0
  • 26. Cont’d The EUDRAGIT grades for enteric coatings are based on anionic polymers of methacrylic acid and methacrylates. They contain –COOH as a functional group. They dissolve at ranges from pH 5.5 to pH 7. Application benefits of enteric EUDRAGIT coatings: PH-dependent drug release Protection of actives sensitive to gastric fluid Protection of gastric mucosa from aggressive actives Increase in drug effectiveness Good storage stability GI and colon targeting
  • 27. Use of Hot melt extrusion in Enteric coating of tablets “ The manufacture and characterization of hot-melt extruded enteric tablets” Eudragit L100-55, an enteric polymer, was pre-plasticized with triethyl citrate (TEC) and citric acid and subsequently dry-mixed with 5-aminosalicylic acid, a model active pharmaceutical ingredient (API). Powder blends were hot-melt extruded as cylinders, cut into tablets. The authors concluded that Increasing the concentration of TEC significantly lowered the glass transition temperature ( T g ) of Eudragit L100-55 and reduced temperatures necessary for extrusion as well as the die pressure.
  • 28. Release profile Influence of method of manufacture on the release of 5-ASA from Eudragit L100-55 tablets in 0.1 N HCl dissolution media (pH 1.2). () HME tablet; (■) compressed tablet with hardness value of 62 ± 2 N; (○) compressed tablet with hardness value of 230 N ± 12 N.
  • 29. Cont’d.. This leads to suggest that hot melt extrusion, a versatile process can be utilized to decrease the compression pressure in order to optimize formulation parameters affecting compressional behavior of materials such as MCC that in conventional enteric coating techniques employ high compressional pressures.
  • 30. Case study 2 Controlled release of dual drug-loaded hydroxypropyl methylcellulose matrix tablet using drug-containing polymeric coatings. By Beom-Jin Lee , , Seung-Goo Ryu and Jing-Hao Cui. Dual drug loaded HPMC matrix tablet that conatins drug in inner tablet core and outer coated layers. Aqueous based Eudragit RS 30 D dispersionis used.
  • 31. Cont’d.. The dual drug-loaded HPMC matrix tablet gave a biphasic linear release, showing a zero-order for 4 h (first) followed by another zero-order release. The current dual drug-loaded HPMC matrix tablet, showing biphasic release profiles may provide an alternative to deliver drugs with circadian rhythmic behaviors in the body. The dual drug-loaded coating method is also interesting for the modified release of poorly water-soluble drugs because solubilizers and other additives can be added in drug-containing polymeric coating dispersions.
  • 32. Future prospects Coating can be dated as back as in ancient times when an experienced individual would dip a bitter tablet into sugar syrup. Since then the process of coating has been constantly an area of interest for oral dosage forms. With the emergence of newer polymers that are pH dependent, acid resistant and many other properties.
  • 33. Cont’d… Utilization of dual coating in case of polymers such as HPMC may result into development of newer techniques in case of coating. Thus it can be concluded that coating has been, is and shall continue to be one of the most promising area in formulation of oral dosage forms for improved health care.
  • 34. Thank us “If we knew what we were doing, it would not be called research”